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Summary
Variations among joints in the initiation and progression of degeneration may be explained, in part, by metabolic, biochemical and
biomechanical differences. Compared to the cartilage in the knee joint, ankle cartilage has a higher content of proteoglycans and water, as
well as an increased rate of proteoglycan turnover and synthesis, all of which are responsible for its increased stiffness and reduced
permeability. Chondrocytes within ankle cartilage have a decreased response to catabolic factors such as interleukin-1 and ﬁbronectin
fragments, compared to the chondrocytes of knee cartilage. Moreover, in response to damage, ankle chondrocytes synthesize proteoglycans
at a higher rate than that found in knee cartilage chondrocytes, which suggests a greater capacity for repair. In addition to the cartilages of the
two joints, the underlying bones also respond differently to degenerative changes. Taken together, these metabolic, biochemical and
biomechanical differences may provide protection to the ankle.
ª 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) is a degenerative joint disease that
involves not only articular cartilage but also synovium, joint
capsule and bone. OA is a common joint disease of the
elderly; however, it does not affect all joints equally1,2, even
in those individuals with generalized OA. Certain features
have been associated with the onset of generalized OA, but
the question of why some joints are affected while others
are not remains unanswered2,3. The joints that are most
often affected by OA include the hip, knee, spine and
metatarsophalangeal joints, as well as both the distal and
proximal interphalangeal joints of the hand. The ankle,
wrist, elbow and shoulder are generally spared from
symptomatic OA. In these nonsymptomatic joints, degen-
eration of the articular cartilage does occur, suggesting that
this degeneration may be nonprogressive, while in suscep-
tible joints degeneration progresses to the disease state.
Poole et al.4 have suggested that an imbalance between
degeneration and repair might help to explain, in part, the
differences among joints in susceptibility to OA. There have
been almost no studies that have compared the cartilages
from different adult human joints in an attempt to identify
features within joints that might either retard or stimulate
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2004.9cartilage degeneration. We had originally proposed that
susceptibility to OA is genetically programmed into the
chondrocytes of some but not all joints. Our laboratories
have concentrated on human articular cartilages of the
ankle (talocrural joint) and the knee (tibiofemoral joint) from
the ipsilateral limb (matched pairs) (Fig. 1) that are available
to us through collaboration with the Gift of Hope Organ and
Tissue Donor Network.
The knee and ankle were chosen for these studies not
only for their availability through the tissue bank but also
because of the dramatic differences in the prevalence of OA
and degeneration between the two joints. While symptom-
atic OA is extremely rare in the ankle joint (!0.1%), almost
10% of the population will develop this disease in the
knee5,6. Although cartilage degeneration cannot be equated
with OA, there is general agreement that degeneration
precedes OA. There have been several studies7,8, including
our own9e11, that have shown that full thickness defects of
the cartilage are higher in the knee compared to the ankle.
It is well accepted that there are numerous anatomical
and biomechanical differences between the knee and ankle
joints that could account for more frequent degenerative
changes in the knee than in the ankle. The knee joint is
a relatively unstable joint composed of the distal femur,
proximal tibia and patella; it is non-congruent and partially
stabilized by menisci and ligaments as well as muscles.
Movement in the knee joint is a mixture of ﬂexion/extension
and rotation. The talocrural (ankle) joint connects the foot
and leg and, like the knee, is also made up of three bones:
the distal tibia, distal ﬁbula and the dome of the talus.
Ligaments and the interosseous membrane between the
tibia and ﬁbula help to make this an extremely stable joint
where movement is limited to extension/ﬂexion. Under high
loads the articular surfaces become highly congruent,
transmitting the weight of the body from the tibia to all the
other weight-bearing bones of the foot. The fact that the
ankle surface is exposed to higher loads per unit surface3
94 K. E. Kuettner et al.: Cartilage degeneration in different jointsFig. 1. Tibiofemoral and talocrural joints. (A) The distal femur and (B) the talus from a 36-year-old man. Both are Grade 0.area than the knee in normal walking12 would suggest
that there are inherent properties of the ankle cartilage
that protect it from the higher compressive loads it
experiences.
In the lower limb, the risk factors for OA include abnormal
biomechanics and trauma, obesity, age, genetic predispo-
sition and higher bone mineral density, as well as
congenital and developmental disorders of bones and
joints13. OA of the knee is more common in women than
in men and is associated with occupations in which there is
high repetitive stress on the joint. OA also develops with
altered joint mechanics that result following menisectomy or
damage to the anterior cruciate ligament. In the ankle, the
major risk factors are abnormal mechanics or trauma, and
the only occupations associated with OA are ballet and
soccer14e17.
The anatomical and biomechanical differences between
the two joints alone do not explain why the knee joint is
more susceptible to OA than the ankle joint. We have
proposed that there must be biochemical and molecular
biologic differences between these two joints that provide
some protection to the ankle. Our studies were designed to
determine whether ankle cartilage is more resistant than
knee cartilage to progressive degeneration and OA due to
either one or all of the following criteria: 1) differences in
biochemical composition and/or biomechanical properties
of the extracellular matrix; 2) decreased response to
catabolic factors; and 3) increased synthetic ability to
repair. At the present time we have data to support all
three components of this hypothesis.
Donor population
In order to compare human adult cartilages from knee
and ankle, we established collaboration with the Gift of
Hope Organ and Tissue Donor Network that has continued
for more than 15 years. During that period we have been
able to acquire knees and ankles from the ipsilateral limb of
donors ranging in age from fetal to 90C years of age (Table
I). In addition, we have acquired unmatched ankles for use
in many of our cartilage studies including those on changes
in cartilage with aging18. Our studies with the ankle cartilage
have allowed us to establish the experimental parameters
that we use for studying normal knee and ankle pairs that
are available in more limited numbers.The proﬁles of the donors from whom we receive joint
tissue reﬂect the donor population available to the tissue
bank11. That population consisted of 73% men and 27%
women, of whom 91% were Caucasian, 6% African
American, 2% Hispanic, and 1% Asian. The average age
was 55.7 years. The most frequent causes of death were
myocardial infarction or cardiopulmonary accident (72%),
accidental death (16%) and stroke (12%). Of the adult
donors that were assessed for weight, 33% of the women
and 23% of the men were considered grossly overweight.
Donor cartilages were excluded from our studies if the
donor was being treated for joint disease (based on reports
by the families of the donors) or had skeletal pathology,
fractures, HIV, hepatitis or diabetes.
Joint grading scale
A ﬁve-point scale originally described by Collins19 for OA
of the knee was modiﬁed by Muehleman et al.9 for use with
the ankle (Fig. 2). In brief, the grades are as follows: Grade
0 joints display no signs of morphologic degenerative
changes with a surface that is smoothly reﬂective and
unﬁbrillated; Grade 1 joints have minimal ﬁbrillations,
shallow pits or grooves affecting the cartilage surface in
the absence of degenerative changes in articular surface
geometry; Grade 2 joints have deep ﬁbrillations and
ﬁssuring, ﬂaking, pitting and/or blistering, early marginal
hyperplasia and, possibly, small osteophytes; Grade 3
joints have extensive ﬁbrillations, ﬁssuring, obvious osteo-
phytes and 30% or less of the articular cartilage surface
eroded down to the subchondral bone; and Grade 4 joints
have prominent osteophytes and greater than 30% of the
articular surface eroded down to the subchondral bone with
gross geometric changes. Because osteophytes are ex-
tremely rare on the talus, the overall grading system for this
Table I
Total number of donors and joints from whom articular cartilage was
available through the Gift of Hope Organ and Tissue Donor
Network between 1993e2003
Donors (Total) 2953 Joints (Total) 5746
Knee/ankle pairs 271 Knee/ankle pairs 507
Ankles only 2682 Ankles only 5239
95Osteoarthritis and Cartilage Vol. 13, No. 2Fig. 2. The ﬁve-point grading scale applied to the talus. The grades are indicated as 0e4. Arrows point to areas of roughening (Grade 1),
ﬁssuring (Grade 2) or full thickness defect (Grade 3). On the Grade 4 talus, the dome is collapsed and more than 30% of the articular cartilage
has been eroded to the subchondral bone. Reproduced from Cole et al.11 with permission.joint focused primarily on the disruption of the cartilage
surface. The distribution of joint grades is listed in Table II.
For our metabolic studies, we included both Grades 0 and 1
as normal because Grade 1 may simply represent normal
senescent changes in the superﬁcial cartilage that may not
be progressive. Joints with Grades 2e4 were classiﬁed as
degenerative.
Based on the data collected since 1993, we have been
able to gain new insights into the degenerative changes in
a population that has not been diagnosed with OA. While an
increase in degenerative changes in the knee with age has
long been accepted20, it was not previously known whether
the same was true for the ankle. Approximately 50% of the
tali had articular surfaces with no macroscopically visible
surface disruptions (Grade 0) compared with 30% of the
femurs. When the ankle grades are analyzed by decade, it is
clear that the percentage of those with Grade 0 decreased
with increasing age; however, compared with the knee,
progression is slower (Fig. 3)11. Interestingly, the percentage
of Grade 0 ankles in the donors 90 years or older increased
to over 50% while only 29% in the 80 year olds received
Grade 0. In fact, none of the tali from donors in the ninth or
tenth decades were Grade 3 or 4. This increase in Grade
0 tali may be due to the fact that cartilage degeneration in the
Table II
Distribution of joint grades. Percentage is based on 4005 ankles
and 405 knees that have been graded
Joint/Grade 0 1 2 3 4
Knee (%) 34 20 25 14 7
Ankle (%) 52 25 19 4.7 0.3ankles of those donors who live longer lives (O90 years of
age) may be progressing even more slowly.
In the ankle, more men (53%) received Grades 2e4 than
women (34%); in the knee, the percentage of higher grades
was also greater in men but the difference was smaller
(60% for women, 67% for men). When the gender differ-
ences were analyzed based on weight, overweight men had
higher grades than normal weight men for both the knee
and ankle. Nearly 50% of the Grade 4 tali were obtained
from overweight men.
In addition to the gender differences, there were other
unexpected ﬁndings10. Our data show that the degree of
degeneration in ankle cartilage is similar in both limbs in the
majority of cases (79% had symmetrical scores). Addition-
ally, in those donors with ankle cartilage degeneration, the
ipsilateral knee cartilage also showed degenerative
changes of an equal or higher grade. These two un-
expected ﬁndings suggest that factors, such as altered
biomechanics, responsible for degeneration in one limb
also cause changes in the contralateral limb and inﬂuence
both the ankle and knee ipsilateral joints.
Adult articular cartilage from the knee
and ankle
Both knee and ankle cartilages have general features
that are typical of articular cartilage21 in that there are no
blood vessels or nerve supply, and nutrition is derived from
the synovial ﬂuid. Articular cartilage protects the underlying
more rigid bone by providing elasticity and resistance to
compressive forces. These properties are conferred by the
two major matrix constituents of the cartilage extracellular
96 K. E. Kuettner et al.: Cartilage degeneration in different jointsmatrix: collagens and proteoglycans. The abundant extra-
cellular organic matrix (98% by volume) of cartilage is
synthesized and maintained by a few sparsely distributed
cells, the chondrocytes.
In both joints, the articular cartilage can be divided into
three main layers e the superﬁcial, middle and deep
(Fig. 4). The matrix of the superﬁcial layer, which contains
ﬂat, disc-shaped chondrocytes, has a relatively low pro-
teoglycan content and collagen ﬁbers parallel to the
surface. In both joints, these specialized superﬁcial layer
cells, but not the chondrocytes deeper in the cartilage,
secrete the superﬁcial zone protein, or SZP, into the
synovial ﬂuid22,23. In the middle and deep zones, the
chondrocytes are more spherical; the matrix has a higher
content of proteoglycan and the collagen orientation
changes from isotropic in the middle to perpendicular to
the surface in the deep layers. The articular cartilage in the
ankle is fairly uniform in thickness (1e1.5 mm) across the
entire surface, while the cartilage of the knee varies from
2e6 mm in thickness. The major difference between the two
cartilages appears to be the thickness of the middle and
deep layers24,25. In the superﬁcial layer, the chondrocytes
are organized into chondrons26; the chondrons in the knee
are composed primarily of single cells, while the chondrons
in the ankle are organized into clusters of two to four cells
each. While there is a dramatic decline in cellular density
between young infants and adult cartilage in both the
superﬁcial and deep layers27, in the adult the cell density
does not change with age in normal cartilage. The cell
densities of the superﬁcial layers of the knee and ankle are
similar, as are the cell densities of the deep layers28.
To analyze changes in cartilage with age in our initial
studies18, we used ankle cartilage because 50% of the
donor talar cartilages were normal (Grade 0). These
analyses show that neither the content of type II collagen
(128G 14 mg/ml wet weight) nor sulfated glycosaminogly-
cans (40.6G 14 mg/mg wet weight) changed with increas-
ing age between 13 and 75 years. However, there is
continuing synthesis and degradation of the matrix compo-
nents throughout life that is primarily associated with the cell
and its pericellular matrix. Type II collagen synthesis was
identiﬁed by mRNA and the C-propeptide (CPII) by
immunoassay. The initial proteolytic processing of the
collagen by collagenases and its subsequent denaturation
were also measured by immunoassay for the collagenase
cleavage and the denaturation neoepitope. While the
cleaved type II collagen showed a trend toward increasing
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Fig. 3. Percentage of Grade 0 by decade in knee and ankle. The
distribution of grades is based on data from 4005 tali and 409
femurs. Donors included in the ninthC decade were 81 to 96 years
of age. Adapted from Cole et al.11 with permission from the
Orthopaedic Research Society.with age, the ratio of cleaved to denatured type II collagen
did show a signiﬁcant increase. These data suggest that in
normal articular cartilage a homeostasis exists with regard
to the turnover of matrix components and that this
predominantly pericellular turnover continues throughout
life. These studies would further suggest that the talar
cartilage may provide an excellent model for studying
changes in cartilage with aging that are distinct
from changes with degeneration as are often found in the
knee.
Comparison of knee and ankle cartilage
BIOCHEMICAL COMPOSITION AND BIOMECHANICAL
PROPERTIES
Our data have shown that there are signiﬁcant differ-
ences in the biochemical composition and biomechanical
properties of the ankle cartilage matrix compared to that of
the knee (Fig. 5)29. For example, in the ankle, the sulfated
glycosaminoglycan content is signiﬁcantly higher and the
water content is signiﬁcantly lower; however, there is no
difference in collagen content. The dynamic stiffness is
higher in ankle cartilage than in knee cartilage, while the
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Fig. 4. Histological sections of full thickness articular cartilage and
subchondral bone from the femur (A) and talus (B) of a 52-year-old
man that were stained with Safranin O and fast green. The relative
positions of the superﬁcial, middle and deep layers of the cartilage
are shown. (Original magniﬁcationZ 4!.)
97Osteoarthritis and Cartilage Vol. 13, No. 2hydraulic permeability is lower, reﬂecting the decreased
water content and higher sulfated glycosaminoglycan
content of the ankle cartilage. These properties could
beneﬁt the ankle cartilage by increasing cartilage stiffness,
thereby protecting the cartilage from the deleterious effects
of higher compressive forces.
The higher compressive stiffness of the ankle cartilage
compared to that of the knee was apparent when the two
cartilages were subjected to injurious compression30. In
order to produce levels of peak stress and visible damage
to human cartilage, a 65% ﬁnal strain was required
producing peak stresses of 11G 1 MPa in knee cartilage
and 16G 1 MPa in ankle cartilage. This compression
resulted in macroscopic tissue changes to 81% of the
knees but only 17% of the ankles.
DIFFERENCES IN SYNTHESIS OF PROTEOGLYCANS
The higher sulfated glycosaminoglycan content of ankle
cartilage correlates with a higher rate of synthesis by ankle
chondrocytes31. When cartilages from the two joints were
assayed in explant culture for differences in synthesis,
ankle cartilage had a higher incorporation rate
(meanZ 28,799 cpm/mg DNA) than those from the knee
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Fig. 5. A comparison of glycosaminoglycan (GAG) content (A),
equilibrium modulus (B), and dynamic stiffness (C) of the femur of
the knee and the talus from the ankle. Bars correspond to the
meanC S.E.; differences were assessed by analysis of variance
and Fisher’s least signiﬁcant difference test, *indicated P! 0.01.
Adapted from Treppo et al.29 with permission from the Orthopaedic
Research Society.(meanZ 15,510 cpm/mg DNA) (Fig. 6). These differences
were maintained over 25 days in culture27 and begin early
in development because they were found in donors as
young as 1-year old31. In addition, ankle cartilage has also
been shown to have higher levels of protein synthesis than
knee cartilage32.
When the turnover of proteoglycans in knee and ankle
cartilages was compared33, the half-life in knee cartilage
was 22.68 days while that in ankle cartilage was 16.58
days. This reduction in the half-life implies that the ankle is
metabolically more active not only in synthesizing proteo-
glycans but also in their degradation. While we do not know
at the present time which proteoglycans are responsible,
our data have shown that there are 2.1 times higher levels
of aggrecan mRNA in ankle chondrocytes compared to
those in the knee. Because aggrecan contains the majority
of the sulfated glycosaminoglycans in the cartilage, it is
probable that this proteoglycan is principally responsible for
the differences.
MODULATION OF SYNTHESIS BY MECHANICAL
COMPRESSION
The synthesis of proteoglycans, collagens and other
proteins can be modulated by static as well as dynamic
mechanical compression; static compression (O10%) has
been previously shown to inhibit proteoglycan and protein
synthesis in a dose-dependent manner in bovine calf
cartilage34,35. When knee and ankle cartilages were
subjected to increasing static compression (0e50%), pro-
teoglycan, collagen and protein synthesis in both the knee
and ankle were altered32,36. In the ankle, collagen synthesis
was suppressed by 15% compression while the synthesis
of proteoglycans and protein were not signiﬁcantly sup-
pressed until the higher strain of 25e50% compression was
applied. Without compression, ankle chondrocytes synthe-
sized signiﬁcantly more protein than those of the knee; with
compression, protein synthesis was increased in knee
chondrocytes to levels similar to those of the ankle
chondrocytes. In the ankle, dynamic compression caused
Fig. 6. Synthesis of glycosaminoglycans (GAG) by matched pairs of
knee and ankle chondrocytes. 35S-incorporation into GAG as cpm
per mg DNA was measured in explants for 4 h after 3 days in
culture. Each measurement is the meanG S.D. in the knee (closed
columns) and ankle (hatched columns) of triplicate samples from
matched pairs (PZ 0.047). Reprinted from Eger et al.31 with
permission from the Orthopaedic Research Society.
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protein, but not of proteoglycans. Dynamic loading caused
an increase in protein synthesis across all ages tested,
emphasizing the importance of regular loading to maintain
cartilage integrity. If knee and ankle chondrocytes were ﬁrst
stripped of their matrices, then seeded into agarose and
allowed to resynthesize a matrix before compression, the
response to loading by both knee and ankle chondrocytes
was no longer signiﬁcantly different. These data suggested
that the differences between knee and ankle chondrocytes
are not genetically programmed into the cells and in
addition, this supports a role of the extracellular matrix in
regulating cellular activity. Because adult articular cartilage
provides a stable microenvironment for the chondrocytes
with extremely low rates of turnover37,38, the presence of
the native matrix is thought to be important in regulating
chondrocyte metabolism.
MAINTENANCE OF CHONDROCYTE PHENOTYPE
Further data from knee and ankle chondrocytes provide
additional supporting evidence that the extracellular matrix
plays a role in inﬂuencing synthesis. If that matrix is ﬁrst
removed and the denuded chondrocytes are allowed to
synthesize a new matrix in alginate beads, there were no
longer signiﬁcant differences in glycosaminoglycan synthe-
sis39, nor were there signiﬁcant differences in their half-
lives. However, differences in the response of knee and
ankle chondrocytes to the catabolic cytokine, interleukin-1b
(IL-1b), were maintained.
DIFFERENCES IN RESPONSE TO CATABOLIC FACTORS
Interleukin-1 (IL-1) at low concentrations is a proinﬂam-
matory catabolic cytokine that has two distinct effects on
human chondrocytes (Fig. 7): at lower concentrations it
suppresses the production of matrix components and in
higher concentrations stimulates the synthesis of proteolytic
enzymes and the degradation of extracellular matrix
components, thereby shifting the metabolic balance from
anabolism to catabolism40. OA may be regarded as
a disorder of cartilage matrix metabolism with intermittent
inﬂammatory episodes superimposed. During these inﬂam-
matory events, IL-1 is released from the inﬂamed synovial
tissue where it is capable of entering the cartilage. The
concentration of IL-1 measured in the synovial ﬂuid from the
joints of patients with arthritis ranges from 13e402 pg/ml41.
The response of chondrocytes to IL-1 in this dose range has
been used to study the effects of a catabolic stimulus on the
cartilage matrix and its ability to repair.
In cartilage explant cultures, the response of ankle
chondrocytes to IL-1b at concentrations of 1e250 pg/ml
was signiﬁcantly different from that of knee chondrocytes
(Fig. 8), demonstrating a reduced response by ankle
chondrocytes to catabolic stimulation compared to knee
chondrocytes31. While both knee and ankle chondrocytes
responded to IL-1 by decreasing 35S-sulfate incorporation
into glycosaminoglycans in a dose-dependent manner, the
dose at which the knee chondrocytes responded was lower
than that for the ankle chondrocytes. At the lowest IL-1
doses tested, 0.1 and 0.5 pg/ml, glycosaminoglycan syn-
thesis was unaffected in both knee and ankle chondrocytes.
However, at an IL-1 dose of 1 pg/ml, glycosaminoglycan
synthesis was reduced by 67% in the knee, but the ankle
chondrocytes were not affected by a similar reduction until
the IL-1 dose was 5 pg/ml. Between IL-1 doses of 5
and 250 pg/ml, there were signiﬁcant differences in thesuppression of glycosaminoglycan synthesis by both knee
and ankle chondrocytes. At the highest IL-1 concentrations
tested (500e1000 pg/ml) there was no longer a signiﬁcant
difference in the suppression of glycosaminoglycan syn-
thesis between knee and ankle; the synthesis in both was
reduced to that of 10% of the control.
The differences in response to catabolic stimulation
between knee and ankle chondrocytes were maintained
when the chondrocytes were released from their native
matrix and cultured in alginate beads. The IC50 for
decreased glycosaminoglycan synthesis by knee chondro-
cytes in alginate was 11.8 pg/ml and was signiﬁcantly
different from that of the ankle, which was 56.1 pg/ml39.
Both of these values are similar to the IC50 found,
respectively, for knee and ankle cartilage explants. The
data showing that both knee and ankle chondrocytes
maintain differences in response to increasing concentra-
tions of IL-1b support our hypothesis that ankle chondrocytes
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Fig. 7. Diagrammatic representation of the inﬂuence of IL-1 on the
chondrocyte. The chondrocyte responds to IL-1 either from
the synovium or from chondrocytes themselves. In human cartilage
the primary response of the chondrocytes is to suppress synthesis
of matrix components at low levels of IL-1; at higher levels of IL-1
enzyme activity is elevated, shifting the metabolic balance between
anabolism and catabolism in favor of matrix degradation. Both
results can be deleterious to the matrix, whether by decreasing
repair or increasing degradation. OA may be considered a disorder
of cartilage matrix metabolism with the superimposition of in-
termittent inﬂammatory episodes.
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cartilages are indicated. Reprinted from Eger et al.31 with
permission the Orthopaedic Research Society.
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regard to decreasing proteoglycan synthesis. These differ-
ences in response to IL-1 may have been caused by either
the number or types of IL-1 receptors42. The chondrocytes of
the superﬁcial zone are more responsive to IL-1 than are
cells from the deeper cartilage. This difference may result
from the higher number of receptors for IL-1 on chondrocytes
from the articular surface than on those from the deep tissue.
It is noteworthy that the IL-1 receptor antagonist protein could
completely block the IL-1 induced inhibition of proteoglycan
synthesis in cells from the ankle joint, but was only partially
effective in knee cartilage cells.
Following injurious compression, knee cartilage, but not
ankle cartilage, responded to treatment with IL-130. When
the cartilage was injured and then exposed to IL-1, there
was a synergistic increased loss of glycosaminoglycan in
the knee. Unlike the results from knee cartilage, in ankle
cartilage from the same donor there was no statistically
signiﬁcant interaction between injury and IL-1 treatment.
These data demonstrate a synergistic effect of cytokines
and cartilage injury found in the adult human knee but not
the ankle, leading to the hypothesis that the interaction
between joint injury and cytokines may be an underlying
difference in the progression to OA of knee and ankle
cartilage after injury.
RESPONSE TO MATRIX FRAGMENTS
Fragments of matrix components, such as ﬁbronectin and
collagen, can have biological activity by activating pathways
that are not part of the native molecule’s normal function43.
A 29 kDa fragment from the amino terminal of ﬁbronectin
has been shown to modulate proteoglycan synthesis at low
doses and degradation at high doses44,45. This fragment,
which can be generated by MMP-3 or other catabolic
proteinases, is elevated in OA synovial ﬂuid and carti-
lage46,47. An injection of the 29 kDa ﬁbronectin fragment
(Fn-f) into the rabbit knee joint causes severe cartilage
damage with characteristics of OA48.
When the Fn-f were incubated with matched pairs of knee
and ankle cartilages, both anti-anabolic as well as catabolic
pathways were activated33,49. Proteoglycan synthesis was
reduced in a dose-dependent manner by both knee and
ankle chondrocytes; however, just as with the response to
IL-1, there was a difference in the concentration at which
proteoglycan synthesis was signiﬁcantly reduced by Fn-f. In
the knee, 1 nM Fn-f signiﬁcantly suppressed proteoglycan
synthesis, while in the ankle, 100 nM was required. There
was also a signiﬁcant difference in the catabolic response of
knee and ankle chondrocytes to stimulation by the 29 kDa
Fn-f. There was greater proteoglycan loss and an increased
activity of aggrecanase in the knee compared with the
ankle; the ankle cartilage was not damaged even after 28
days in culture. The knee cartilage showed a signiﬁcant loss
of 30e50% of its proteoglycan as early as day 7. When the
rate of degradation, measured as proteoglycan loss to
the media during 7 days of explant culture, was determined,
the rates for the knee and ankle were nearly identical. In the
presence of the 29 kDa Fn-f, the degradation rates
signiﬁcantly increased to 0.68G 0.28 mg proteoglycan/mg
cartilage/day for knee cartilage and 0.58G 0.14 mg pro-
teoglycan/mg cartilage/day for ankle cartilage. In addition,
the 29 kDa Fn-f signiﬁcantly decreased the half-life of 35S-
labeled proteoglycan by 1.87-fold in the knee and 2.36-fold
in the ankle, both compared to the control.
While the inﬂuence of Fn-f has primarily focused
on proteoglycan regulation, studies of type II collagenfragments have focused on collagen synthesis. It was
previously thought that adult human cartilage no longer
synthesized type II collagen50,51; however, it has recently
been shown that collagen synthesis evaluated by mRNA
and the CPII continues in articular cartilage, albeit at low
levels18. Collagen is also continuously turned over through-
out life as well18, such that collagen fragments accumulate
in the normal matrix at a concentration of 1e4 mg/g wet
weight of the cartilage; OA cartilages contain between 7
and 17 mg/g wet weight52. Incubation of knee and ankle
explants with collagen fragments for 21 days results in
a signiﬁcant loss of glycosaminoglycans as well as collagen
from the explants; however, there were no signiﬁcant
differences in the loss between knee and ankle52.
ATTEMPTED REPAIR
Another reason for the lack of damage progression in
ankle cartilage may be that ankle chondrocytes, which are
more responsive to anabolic agents than knee chondro-
cytes, are thus able to repair early cartilage lesions. The
anabolic factor osteogenic protein-1 (OP-1, also known as
bone morphogenetic protein-7) caused a marked stimula-
tion of proteoglycan and collagen synthesis (mostly
aggrecan and type II collagen) in human articular chon-
drocytes. OP-1 had a much more potent anabolic effect
compared to other factors including TGF-1b, activin A, and
IGF-153. When OP-1 was tested in combination with low
concentrations of IL-1, OP-1 was able to overcome the
inhibitory effect of IL-1 on aggrecan synthesis. When knee
and ankle explants were ﬁrst incubated with IL-1b and then
allowed to rebound without IL-1b, the synthesis of proteo-
glycans was signiﬁcantly elevated by ankle chondrocytes
within 5 days; knee chondrocytes were unable to signiﬁ-
cantly increase synthesis even after 8 days. In alginate
beads no differences were found in the response of either
knee or ankle chondrocytes to a monoclonal anti-OP-1
neutralizing antibody that suppressed proteoglycan synthe-
sis and endogenous OP-1 content54.
Differences in knee and ankle cartilage
response to degenerative changes
In an attempt to compare the knee and ankle in vivo
response to damage, we analyzed markers of synthesis
and degradation in cartilage from joints that were Grade
0 (normal) and Grade 2 (early lesions). The results indicate
a net anabolic response in the ankle cartilage lesion and
a net catabolic response in knee cartilage lesions55. In
ankle cartilage lesions, there was an upregulation of the
markers of collagen synthesis and of proteoglycan synthe-
sis which were downregulated in the knee cartilage lesions.
In lesions of knee cartilage, but not ankle cartilage, there
was a ﬁve-fold upregulation of collagen degradation
markers. Compared to the ankle, there was a 24-fold
increase in cleavage epitopes compared to denaturation
epitopes in knee cartilage lesions. The upregulation of
matrix turnover that was seen in early cartilage lesions of
the ankle would appear to represent an attempt to repair the
damaged matrix. The increase in collagen synthesis and
aggrecan turnover seen in ankle lesions was absent from
the knee lesions. Instead, there was an increase in type II
collagen cleavage. Taken together with the differences in
collagen denaturation, these changes point to the stimula-
tion of matrix assembly during early lesion development in
ankle cartilage and of degradation of the matrix in knee
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turnover within lesions in ankle and knee cartilage. The
increase in type II collagen cleavage in early lesions of knee
cartilage, but not in ankle cartilage, suggests an early
predisposition to degenerative pathology in the knee, while
in the ankle the early emphasis is on repair.
Response of subchondral bone to
degenerative changes in cartilage
OA is characterized by both articular cartilage degener-
ation and subchondral bone changes; early degenerative
changes in the cartilages of the knee, hip, and ﬁnger joints
with progression to OA show increased subchondral bone
density56. We therefore investigated whether the degree of
degeneration of ankle cartilage (mild or moderate) corre-
lates with an elevated bone density in the ankle57. Using
peripheral quantitative computed tomography, we found
that even moderate degeneration of the articular cartilage of
the ankle is not accompanied by an increase in local bone
density, but rather shows an associated decrease. In the
ankle, cartilage degeneration appears to precede thicken-
ing of the subchondral bone. Because the ankle joint is
generally not affected by progressive OA, the lack of
association between increased bone density and cartilage
degeneration would appear to support the idea that
progressive degeneration of the cartilage requires bone
involvement.
Conclusions
Our studies comparing knees and ankles have shown
that there are differences not only in the cartilage andsubchondral bone but also in the chondrocytes themselves,
which may contribute to degeneration in the knee and repair
in the ankle (Table III). The accumulation of this data has
been possible through collaboration with the Gift of Hope
Organ and Tissue Donor Network and continuous support
through a grant from NIH for a SCOR in OA. The studies
have been conducted not only by intramural investigators
but also by a number of extramural investigators who have
contributed their expertise and unique techniques and
reagents to compare knee and ankle cartilages as well as
bone. The success of these studies may be attributed to the
fact that we have been able to study normal knee and
ankles from the ipsilateral limb of a large number of adult
donors. Each of these studies has taken 2 to 3 years to
complete and, thus, has proceeded at a slower pace than
the average successful research project.
Our most convincing data were obtained from experi-
ments with cartilage explants where the chondrocytes
remained in their accumulated native matrix. The pro-
teoglycan content of the extracellular matrix is signiﬁcantly
higher in ankle cartilage than in knee cartilage. The higher
proteoglycan content, along with lower water content,
provide an increased stiffness and lower hydraulic perme-
ability to ankle cartilage. The result is a higher compressive
stiffness that could protect ankle cartilage from continuous
microtrauma. The lack of a synergistic response of ankle
chondrocytes to injurious compression and IL-1 suggests
that, even with traumatic injury, ankle cartilage is more
resistant to the progression of degeneration. Together,
these data show that the extracellular matrix plays
a signiﬁcant role in protecting the cartilage in the ankle.
The extracellular matrix also plays a role in maintaining
the differences between knee and ankle cartilage. In
a number of our studies, the chondrocytes were ﬁrstTable III
Summary of knee and ankle differences
Feature Knee Ankle
Joint stability Relatively unstable Highly stable
Non-congruent Highly congruent
Joint motion Flexion/extension Flexion/extension
Rotation
Cartilage
Cellularity Same Same
Cartilage thickness 2e6 mm 1e1.5 mm
Superﬁcial chondrons Single cells Clusters of 2e4 cells
Sulfated glycosaminoglycan content Lower Higher
Water content Higher Lower
Collagen content Same Same
Dynamic stiffness Lower Higher
Hydraulic permeability Higher Lower
Peak stress with 65% ﬁnal strain 11 MPa 16 MPa
Glycosaminoglycan synthesis
In explants Lower Higher
In alginate Same Same
Proteoglycan half-life 22.68 days 16.58 days
Protein synthesis Lower Higher
IC50 for IL-1 reduction of proteoglycan synthesis
In alginate 11 pg/ml 56 pg/ml
In explants 6 pg/ml 35 pg/ml
Inﬂuence of Fn-fs on
Proteoglycan synthesis (anti-anabolic) Low dose (1 nM) High dose (100 nM)
Proteoglycan loss (catabolic) Signiﬁcant at 7 days Not signiﬁcant after 28 days
Attempted repair (Response to anabolic factors
following catabolic stimulation)
No signiﬁcant rebound Signiﬁcant rebound
Response to degeneration Upregulation of collagen
degradation
Upregulation of matrix
synthesis
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a new matrix in either alginate or agarose. In the newly
formed matrix, there were no longer signiﬁcant differences
in response to compression, nor were the differences in
proteoglycan content or synthesis maintained. However,
there were differences that were not lost, such as the dose
response to IL-1, suggesting that some of these differences
were programmed into the chondrocytes themselves re-
gardless of their extracellular matrix, just as was previously
shown for superﬁcial and deep chondrocytes. Differences in
response to IL-1 may be due to differences in either the
number or types of IL-1 receptors that are maintained in
both superﬁcial and deep chondrocytes taken from knee
and ankle.
Ankle chondrocytes display a decreased response to not
only IL-1 but also to other catabolic factors, such as Fn-f in
explant cultures. In addition, ankle chondrocytes have an
increased response to anabolic agents, such as OP-1.
These data are supported by our analyses of markers of
degradation and synthesis in vivo. Damaged (Grade 2)
ankle cartilage contains higher levels of CPII, indicative of
collagen synthesis, and 846-epitope, indicative of pro-
teoglycan synthesis, accompanied by lower levels of
degradation neoepitopes. Although degeneration occurs in
ankle cartilage, its progression may be slower compared to
the knee due to the continuing attempts to repair.
The ankle appears to provide an in vivo model for
studying reparative response mechanisms that are not
present in the knee. Our current data suggest that there is
not a single property, but numerous subtle differences
between the cartilages, as well as the bone, from the two
joints, which could help protect the ankle cartilage from
progressive degenerative changes. By understanding how
knee and ankle cartilages differ from one another, we can
begin to identify factors active in the early stages of
cartilage damage that may precede OA. Our ultimate goal
in OA research is to develop the means of blocking the
progression of the disease process and to reverse its
effects. One method of reversing the effects of early
disease processes is to decrease the response of
chondrocytes to catabolic factors and to stimulate the
chondrocytes to rebuild their matrix. Effectively, simulating
the characteristics of ankle chondrocytes in different joints
should facilitate the development of therapeutic strategies
for the early detection and prevention of OA. The ankle may
provide a model for studying reparative response mecha-
nisms that are absent or diminished in the knee.
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